X-154030710-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The NM_001110792.2(MECP2):c.1154C>A(p.Ser385*) variant causes a stop gained change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001110792.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- chromosome Xq28 duplication syndromeInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- Rett syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
- severe neonatal-onset encephalopathy with microcephalyInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- syndromic X-linked intellectual disability Lubs typeInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked intellectual disability-psychosis-macroorchidism syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- systemic lupus erythematosusInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MECP2 | NM_001110792.2 | MANE Select | c.1154C>A | p.Ser385* | stop_gained | Exon 3 of 3 | NP_001104262.1 | ||
| MECP2 | NM_004992.4 | MANE Plus Clinical | c.1118C>A | p.Ser373* | stop_gained | Exon 4 of 4 | NP_004983.1 | ||
| MECP2 | NM_001316337.2 | c.839C>A | p.Ser280* | stop_gained | Exon 5 of 5 | NP_001303266.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MECP2 | ENST00000453960.7 | TSL:1 MANE Select | c.1154C>A | p.Ser385* | stop_gained | Exon 3 of 3 | ENSP00000395535.2 | ||
| MECP2 | ENST00000303391.11 | TSL:1 MANE Plus Clinical | c.1118C>A | p.Ser373* | stop_gained | Exon 4 of 4 | ENSP00000301948.6 | ||
| MECP2 | ENST00000630151.3 | TSL:5 | c.1118C>A | p.Ser373* | stop_gained | Exon 4 of 4 | ENSP00000486089.2 |
Frequencies
GnomAD3 genomes AF: 0.0000181 AC: 2AN: 110268Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.0000169 AC: 3AN: 177404 AF XY: 0.00 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000548 AC: 6AN: 1095368Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 361304 show subpopulations
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000181 AC: 2AN: 110268Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32468 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: MECP2 c.1118C>A (p.Ser373X) results in a premature termination codon, predicted to cause a truncation of the C-terminal segment of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele (described as ChrX:153296161G>T) was found at a frequency of 1.7e-05 in 174031 control chromosomes (in gnomAD), however this nucleotide change might occur as a part of a complex variant with two other missense variants (c.1115A>C and c.1117T>C) that would translate into a different protein level change, therefore these data might not be reliable for assessing variant frequency. Although the pattern of reads in the gnomAD database indicates a complex origin, the possibility of this variant occuring in isolation in patients with Rett syndrome cannot be entirely ruled out. Furthermore, a different nucleotide change (c.1118C>G) resulting in a variant described identically at the protein level as p.Ser373X, has been reported in the literature in an individual affected with either classic or a variant form of Rett Syndrome (Smeets 2009 cross references with HGMD database). In this study, the authors report that complete data were obtained on 103 RTT females clinically diagnosed between 1983 and 2003 according to the international diagnostic criteria for classic and variant RTT. However the specific phenotype of the patient harboring p.Ser373X was not specified. The authors of the study concluded that 'late' truncating mutations in the C-terminal segment develop differently in the long term and remain milder far into adult life. As this publication does not specify the exact nucleotide level change observed in this patient and does not provide any information about other variants in the MECP2 gene present in this individual, it does not provide unequivocal conclusions about association of the variant of interest (namely, c.1118C>A) with either classic or variant Rett Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as a variant of uncertain clinical significance (VUS).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at